Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sims

Showing results (461-470 of 528) with videos related to

Pageof 53
Sort By:
Frontiers in Medicine|August 20, 2021
Oral Scutellarin Treatment Ameliorates Retinal Thinning and Visual Deficits in Experimental GlaucomaJingyuan Zhu, Anoop Sainulabdeen, Krystal Akers, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 4, 2025
Donanemab immunogenicity in participants with early symptomatic Alzheimer's diseaseGarrett R Mullins, Paul Ardayfio, Ivelina Gueorguieva, et al.
Alcoholism, Clinical and Experimental Research|November 22, 2013
Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- miceKelly E Mercer, Clark R Sims, Carrie S Yang, et al.
Journal of Veterinary Internal Medicine|March 11, 2026
Endogenous calcitriol production and ionized hypercalcemia in 7 dogs with chronic dermatopathy of infectious and noninfectious etiology (2016-2024)Jean M Brudvig, Daniel K Langlois, Jared A Jaffey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 20, 2025
TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's diseaseStephen Salloway, Andrew Pain, Elly Lee, et al.
The Journal of Prevention of Alzheimer'S Disease|March 29, 2016
A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS)A M Wessels, E R Siemers, P Yu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 21, 2023
Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's diseaseSergey Shcherbinin, Amanda Morris, Ixavier A Higgins, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task ForceS Gauthier, J Alam, H Fillit, et al.
Journal of X-Ray Science and Technology|February 11, 2011
The X-Ray CCDs Developed for the Joint European X-Ray TelescopeA Owens, A F Abbey, H Brauninger, et al.
Nature Communications|March 2, 2024
High-density volumetric super-resolution microscopySam Daly, João Ferreira Fernandes, Ezra Bruggeman, et al.
Pageof 53

Showing results (461-470 of 528) with videos related to

Sort By:
Pageof 53
Frontiers in Medicine|August 20, 2021
Oral Scutellarin Treatment Ameliorates Retinal Thinning and Visual Deficits in Experimental GlaucomaJingyuan Zhu, Anoop Sainulabdeen, Krystal Akers, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 4, 2025
Donanemab immunogenicity in participants with early symptomatic Alzheimer's diseaseGarrett R Mullins, Paul Ardayfio, Ivelina Gueorguieva, et al.
Alcoholism, Clinical and Experimental Research|November 22, 2013
Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- miceKelly E Mercer, Clark R Sims, Carrie S Yang, et al.
Journal of Veterinary Internal Medicine|March 11, 2026
Endogenous calcitriol production and ionized hypercalcemia in 7 dogs with chronic dermatopathy of infectious and noninfectious etiology (2016-2024)Jean M Brudvig, Daniel K Langlois, Jared A Jaffey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 20, 2025
TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's diseaseStephen Salloway, Andrew Pain, Elly Lee, et al.
The Journal of Prevention of Alzheimer'S Disease|March 29, 2016
A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS)A M Wessels, E R Siemers, P Yu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 21, 2023
Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's diseaseSergey Shcherbinin, Amanda Morris, Ixavier A Higgins, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task ForceS Gauthier, J Alam, H Fillit, et al.
Journal of X-Ray Science and Technology|February 11, 2011
The X-Ray CCDs Developed for the Joint European X-Ray TelescopeA Owens, A F Abbey, H Brauninger, et al.
Nature Communications|March 2, 2024
High-density volumetric super-resolution microscopySam Daly, João Ferreira Fernandes, Ezra Bruggeman, et al.
Pageof 53